Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism Siglec-8 inhibitors(Sialic acid-binding Ig-like lectin 8 inhibitors), Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nasal Polyps | Phase 2 | DE | 01 Apr 2016 | |
Nasal Polyps | Phase 2 | BE | 01 Apr 2016 | |
Nasal Polyps | Phase 2 | GB | 01 Apr 2016 | |
Nasal Polyps | Phase 2 | US | 01 Apr 2016 | |
Nasal Polyps | Phase 2 | NL | 01 Apr 2016 | |
Dermatitis, Atopic | Phase 2 | US | 01 Sep 2015 | |
Hypersensitivity | Phase 2 | US | - | |
Nasal Polyps | Preclinical | ES | 01 Apr 2016 |
Phase 2 | 40 | (25 mg AK001) | bbpdqhtdlb(tpuvgfdhxy) = cjlivkkddh stjyakiohs (fzvabjxqgt, nlzxrgdhkw - cytrskcqtm) View more | - | 28 Dec 2020 | ||
(250 mg AK001) | bbpdqhtdlb(tpuvgfdhxy) = ckjnugnpdd stjyakiohs (fzvabjxqgt, jpzozvgkne - uvlhsdzdwy) View more |